“…At present, there are limited data to guide treatment selection based on clinical characteristics, biomarkers, or genetic variations that reliably predict differential effectiveness or adverse effects for specific treatments for very common presenting problems such as depression or anxiety (Hahn et al, 2015; Schneider, Arch, & Wolitzky-Taylor, 2015; Simon & Perlis, 2010), and when there are predictions, they are based on numerous considerations that result in algorithms or empirically based indices to inform treatment selection (DeRubeis et al, 2014; Huibers et al, 2015; Kraemer, 2013). While tools to use assessment of patient progress and functioning to guide treatment have been developed in the past decade (cf., Lambert, 2007; Tsai, Moskowitz, Brown, Park, & Chorpita, 2016), none of this research or these strategies was used or mentioned by anyone in our sample. Additionally, no clinicians described selecting a treatment approach based on a patient’s preference, despite the current emphasis of patient-oriented care.…”